9 Results (Page 1 of 1)
UAE Free Sample Markets Research Reports
UAE Dental Care Market Analysis Sample Report
The UAE dental care market size is at around $179 Mn in 2022 and is projected to reach $318 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period from 2022 to 2030. The market is growing as the new medical tourism destination for dental care services and is dominated by players like American Dental Clinic, Dr. Sulaiman Al Habib Medical Group, Aster DM Healthcare, and Medcare Hospitals & Medical Centers.
UAE Home Healthcare Market Analysis Sample Report
The UAE home healthcare market was valued at $1.83 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $3.59 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, many insurances now include home healthcare. The market is segmented by equipment outlook and by services. Some key players in this market are Omega Home Health Care, Ishraq home healthcare, bayti Home Healthcare, Manzil, Mediclinic, NMC Health, and Alleanza.
Abu Dhabi Oncology Drugs Market Analysis Sample Report
The Abu Dhabi oncology drugs market is projected to grow from $296.3 Mn in 2022 to $635.2 Mn in 2030 with a CAGR of 10% for the year 2022-2030. Geriatric population growth and technological advancements in the treatment of cancer in Abu Dhabi are the major market drivers. AstraZeneca and Pfizer are the key players in the Abu Dhabi oncology drugs market.
Dubai Home Healthcare Market Analysis Sample Report
The Dubai home healthcare market is projected to grow from $271.06 Mn in 2022 to $362.5 Mn in 2030 with a CAGR of 3.7% for the year 2022-2030. The market is segmented by product, service, and by indication. Aims Healthcare and Manzil Healthcare are the key players in the Dubai home healthcare market.
UAE Oncology Drugs Market Analysis Sample Report
By 2030, it is anticipated that the UAE oncology drugs market will reach a value of $2.54 Bn from $0.98 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in UAE is dominated by a few large pharmaceutical companies such as Biopharma Middle East & Africa, Neopharma Pharmaceutical Plant, and Newbridge Pharmaceuticals FZ LLC. The oncology market in UAE is segmented by different therapeutic areas, into breast cancer, lung cancer, colorectal cancer, prostate cancer, and others. The market is also segmented based on treatment types, such as surgery, radiation therapy, chemotherapy, and targeted therapy.
UAE Nutritional Supplements Market Analysis Sample Report
By 2030, it is anticipated that the UAE nutrition and supplements market will reach a value of $3.94 Bn from $1.91 Bn in 2022, growing at a CAGR of 9.5% during 2022-30. The market is primarily dominated by local players such as Vitabiotics Ltd, Bayer Middle East, and Forever Living Products. The market for nutrition and supplements in the UAE is primarily driven by reimbursement scenarios, increasing consumer awareness for health and lifestyle, and international supplements business. The UAE nutrition and supplements market in UAE is segmented by Type, Product, application, and Distribution Channel.
UAE Anti Aging Therapeutics Market Analysis Sample Report
UAE anti-aging therapeutics market is projected to grow from $3 Mn in 2022 to $11 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. The market is projected to expand as a result of the growing demand for anti-aging treatments and rising disposable incomes in the UAE. The UAE anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Insilico Medicine, Kuwait Saudi Pharmaceuticals, and Alkahest are the top players in the market.
UAE LASIK Surgery Market Analysis Sample Report
UAE LASIK Surgery Market was valued at $17.65 Mn in 2023 and is predicted to grow at a CAGR of 6.21% from 2023 to 2030, to $ 26.91 Mn by 2030. The key drivers of this industry include rising prevalence, high disposable income, and medical tourism destinations. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
UAE Orphan Diseases Drugs Market Analysis Sample Report
The UAE Orphan Diseases Drugs Market is projected to grow from $0.774 Bn in 2022 to $1.823 Bn by 2030, registering a CAGR of 11.30% during the forecast period of 2022 - 2030. UAE has a large patient population with rare diseases, and a growing elderly population is increasing the demand for treatments for these conditions Some of the leading players in the market include Pfizer, Sanofi, Roche, and Novartis.